PACB vs TXG (Pacific Biosciences of California Inc. vs 10x Genomics Inc.)
Showing Closing Date Range from Oct 6 to Oct 7, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
Today's Session Official Close
The regular trading session has completed and official closing prices are verified as of 11:37 PM ET. All metrics below represent finalized session performance.
PACB leads by +6.39% Alpha Spread Today
PACB is trading at +0.74% while TXG is at -5.65% .
Started At
Official opening auction price
Closed At
Official exchange closing price
Gained / Lost Today
Net return against previous session close
Today's Trading Range Position
Where each asset is currently trading relative to its Day Low and Day High
Session Liquidity & Volume
Trading activity, share volume, and estimated dollar liquidity
Session Ledger Comparison
Direct side-by-side breakdown of today's key auction and price metrics
| Metric | PACB | TXG | Head-to-Head Advantage |
|---|---|---|---|
| Today's Return | +0.74% | -5.65% | PACB +6.39% |
| Net Dollar Move | +$0.02 | $-4.56 | PACB higher move |
| Open Price | $2.62 | $77.52 | Gap: -2.96% vs -3.89% |
| Day High | $2.74 | $82.72 | Session peaks |
| Day Low | $2.50 | $73.00 | Session troughs |
| Intraday Spread | $0.24 | $9.72 | High/Low spread |
| Share Volume | 20.28M | 9.37M | PACB more active |
| Est. Dollar Volume | $55.16M | $713.04M | TXG higher liquidity |
Explore PACB vs TXG Over Extended Timeframes
Today's session isolates intraday momentum. Switch to normalized multi-day timeframes to analyze historical correlations, cumulative returns, and divergence charts.